Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
6
×
seattle blog main
seattle top stories
texas blog main
6
×
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
celgene
drug prices
pfizer
president trump
brexanolone
cancer
cancer immunotherapy
congress
deals
genentech
heart disease
What
drug
6
×
roundup
bio
gene
pharmaceutical
prices
today
adu
advanced
ahead
alnylam’s
alzheimer’s
ambien
american
annual
approval
approved
asco
attendees
attention
away
beats
bff
bids
biogen
biotech
bringing
camp’s
cancer
cash
ceos
chicago
cholesterol
city
clinical
combinations
community’s
companies
complicated
conference
Language
unset
Current search:
sanofi
×
drug
×
" texas blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More